首页 | 官方网站   微博 | 高级检索  
     

朗格汉斯细胞在特应性皮炎免疫机制和治疗中的作用
引用本文:朱晨曦,姚志荣.朗格汉斯细胞在特应性皮炎免疫机制和治疗中的作用[J].中国麻风皮肤病杂志,2020,36(10):631-635.
作者姓名:朱晨曦  姚志荣
作者单位:上海市新华医院皮肤科,上海,200092
摘    要:特应性皮炎是一种涉及多种免疫细胞的慢性复发性炎症性皮肤病,朗格汉斯细胞在其发病中起着重要作用。研究表明朗格汉斯细胞在发病早期迁移至皮肤淋巴结,活化并主导Th2型免疫反应。治疗方面,倍他米松、大环内酯类抗生素可以抑制朗格汉斯细胞诱导Th2型炎症,而焦油和组胺4受体拮抗剂则可抑制朗格汉斯细胞表达CCL17和CCL22。本文对朗格汉斯细胞在特应性皮炎免疫机制和治疗中的作用进行了综述。

关 键 词:特应性皮炎  朗格汉斯细胞  免疫反应  丝聚蛋白  

Update of the role of langerhans cell in the immune mechanism and treatment in atopic dermatitis
ZHU Chenxi,YAO Zhirong.Update of the role of langerhans cell in the immune mechanism and treatment in atopic dermatitis[J].China Journal of Leprosy and Skin Diseases,2020,36(10):631-635.
Authors:ZHU Chenxi  YAO Zhirong
Affiliation:Department of Dermatology, Shanghai Xinhua Hospital, Shanghai 200092, China
Abstract:Atopic dermatitis is a chronic relapsing inflammatory skin disease that involves a variety of immune cells. The langerhans cell plays an important role in starting and maintaining the disease. The migration of langerhans cell to the skin lymph nodes happens at the early stage of the dermatitis, and then, it gets activated and leads to Th2 type immunoreaction. In terms of treatment, betamethasone and macrolide antibiotics can inhibit langerhans cell-induced Th2-type inflammation. Tar and histamine 4 receptor antagonists can inhibit the expression of CCL17 and CCL22 by langerhans cell. The update of the role of langerhans cell in the immune mechanism and treatment in atopic dermatitis is reviewed in this paper.
Keywords:atopic dermatitis  langerhans cells  immune response  filaggrin  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息
点击此处可从《中国麻风皮肤病杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号